GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (FRA:IG7) » Definitions » Short Percentage of Float

Memphasys (FRA:IG7) Short Percentage of Float


View and export this data going back to 2019. Start your Free Trial

What is Memphasys Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Memphasys's Short Percentage of Float

For the Biotechnology subindustry, Memphasys's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Memphasys's Short Percentage of Float Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Memphasys's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Memphasys's Short Percentage of Float falls into.


Memphasys (FRA:IG7) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Memphasys Ltd (FRA:IG7) » Definitions » Short Percentage of Float
Comparable Companies
ASX:AVE ASX:ATX ASX:ANR ASX:ZLD ASX:TRP ASX:BTC ASX:VBS ASX:NSB ASX:BGT ASX:ILA OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
MEM:Australia
Address
30 Richmond Road, Homebush, Sydney, NSW, AUS, 2140
Website
https://www.memphasys.com
Memphasys Ltd is an Australian-based emerging small-cap reproductive biotechnology company. It develops and commercializes novel reproduction and fertility solutions for humans and animals. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Memphasys (FRA:IG7) Headlines

No Headlines